Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on June 4, 2025
Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action
GlobeNewswire
·
June 4, 2025
TARPON SPRINGS, Fla., June 4, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as …
Integral Metals Engages Geological Consultant for KAP Project Desktop Study and Resource Planning
GlobeNewswire
·
June 4, 2025
CALGARY, Alberta, June 04, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it has engaged Understood Mineral Resources Ltd. (“UMR”), a geological and …
Fusion Fuel Green PLC Announces Forthcoming Annual General Meeting
GlobeNewswire
·
June 4, 2025
DUBLIN, June 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”) today announced that it will hold its Annual General Meeting (“AGM”) on June 25, 2025, at 2:00 PM (Dublin time) at the offices of …
Pride Month: myGwork’s Free WorkPride 2025 Conference Empowers Allies to Step Up
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- Tightening DEI regulations in the US and recent rulings – such as the UK Supreme Court’s narrowing of the legal definition of “sex” – are creating growing uncertainty in workplaces worldwide. These developments not …
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
GlobeNewswire
·
June 4, 2025
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic inflammation and its fundamental role in the complex cycle of …
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 4, 2025
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET. The …
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
GlobeNewswire
·
June 4, 2025
Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as …
IQ121 Launches Advanced Legacy Building App, Digitally Safeguarding Vital Documents and Preserving Cherished Memories
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- A loved one's passing brings both emotional pain and the heavy weight of complex legal and administrative tasks, leaving families with more to manage than just grief during their time of loss. Today, IQ121 …
IQ121 Launches Advanced Legacy Building App, Digitally Safeguarding Vital Documents and Preserving Cherished Memories
GlobeNewswire
·
June 4, 2025
LONDON, June 04, 2025 (GLOBE NEWSWIRE) -- A loved one's passing brings both emotional pain and the heavy weight of complex legal and administrative tasks, leaving families with more to manage than just grief during their time of loss. Today, IQ121 …
Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity
GlobeNewswire
·
June 4, 2025
BURLINGAME, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Today, Accumulus Synergy (“Accumulus”) announced a strategic partnership with Veeva Systems (“Veeva”) focused on enabling connectivity to help the life sciences industry more effectively exchange …
Accumulus Synergy und Veeva Systems gehen eine Partnerschaft ein, um die Transformation der Regulierung und die Konnektivität voranzutreiben
GlobeNewswire
·
June 4, 2025
BURLINGAME, Kalifornien, June 04, 2025 (GLOBE NEWSWIRE) -- Accumulus Synergy („Accumulus“) hat heute eine strategische Partnerschaft mit Veeva Systems („Veeva“) bekannt gegeben, deren Schwerpunkt auf der Bereitstellung von Konnektivität liegt, um die Life- …
アキュミュラス・シナジー (Accumulus Synergy) とヴィーバ・システムズ (Veeva Systems)、規制の変革と接続性の促進に向けて提携
GlobeNewswire
·
June 4, 2025
カリフォルニア州バーリンゲーム発, June 04, 2025 (GLOBE NEWSWIRE) -- 本日、アキュミュラス・シナジー (「アキュミュラス」) は、ライフサイエンス業界が世界中の各国規制当局 (NRA) と規制対象情報をより効果的に交換できるよう支援することを目的とした、接続性の実現に焦点を当てたヴィーバ・システムズ (「ヴィーバ」) …
Accumulus Synergy et Veeva Systems s’associent afin d’accélérer la transformation réglementaire et la connectivité
GlobeNewswire
·
June 4, 2025
BURLINGAME, Calif., 04 juin 2025 (GLOBE NEWSWIRE) -- Accumulus Synergy (« Accumulus ») a annoncé aujourd’hui un partenariat stratégique avec Veeva Systems (« Veeva ») axé sur la mise en place de solutions de connectivité permettant au secteur des sciences …
La rétention de talents : un sujet clé pour les ESN
GlobeNewswire
·
June 4, 2025
Sur un marché toujours plus tendu, le recrutement d’experts est un sujet stratégique qui mobilise des ressources conséquentes. En effet, capter des talents est aujourd’hui un défi de tous les jours pour les DRH qui doivent rivaliser d’originalité et d’ …
British Council 通过 Action Research 计划推动教育创新，造福全球教育工作者
GlobeNewswire
·
June 4, 2025
British Council 大力支持 Action Research 计划，切实助益全球多所学校，由此确立自身作为国际教育进步关键推动者的地位。 由教育工作者主导的创新研究项目改善了巴基斯坦、埃及、哥伦比亚等国的教学质量，为当地学校带来可量化的成果。 一项基于人工智能的数学项目提升了学生的理解力和学习成绩。 80% 的学生表示，使用数字平台增强了他们通过主动学习和运用批判性思维解决问题的能力。 北京, June 04, 2025 (GLOBE NEWSWIRE) -- British Council …
The British Council drives educational innovation through Action Research, benefiting educators worldwide
GlobeNewswire
·
June 4, 2025
The British Council has established itself as a key facilitator of international educational improvement by supporting Action Research as a platform that has delivered tangible progress in schools worldwide. Innovative educator-led research projects have …
TOLREMO therapeutics Announces TT125-802 is the First CBP/p300 Bromodomain Inhibitor to Show Clinical Activity in Solid Tumors
GlobeNewswire
·
June 4, 2025
- Deep and durable responses in drug-resistant KRAS-G12C- and EGFR-mutant NSCLC - Best-in-class safety profile highlights potential for development in combination to treat patients with KRAS-G12C-mutant NSCLC, EGFR-mutant NSCLC and R/R multiple myeloma …
Hội đồng Anh thúc đẩy sáng kiến đổi mới giáo dục thông qua chương trình Nghiên cứu Hành động, mang lại lợi ích cho các nhà giáo dục trên toàn thế giới
GlobeNewswire
·
June 4, 2025
Hội đồng Anh đã khẳng định vai trò là đơn vị tiên phong trong việc nâng cao chất lượng giáo dục toàn cầu bằng cách hỗ trợ chương trình Nghiên cứu Hành động như một nền tảng mang lại những tiến bộ rõ rệt trong các trường học trên khắp thế giới. Các dự án …
The British Council drives educational innovation through Action Research, benefiting educators worldwide
GlobeNewswire
·
June 4, 2025
The British Council has established itself as a key facilitator of international educational improvement by supporting Action Research as a platform that has delivered tangible progress in schools worldwide. Innovative educator-led research projects have …
The British Council drives educational innovation through Action Research, benefiting educators worldwide
GlobeNewswire
·
June 4, 2025
The British Council has established itself as a key facilitator of international educational improvement by supporting Action Research as a platform that has delivered tangible progress in schools worldwide. Innovative educator-led research projects have …